Clinical strategies in the medical care of Jehovah's witnesses

被引:28
作者
Remmers, Paul A. [1 ]
Speer, Alice J. [1 ]
机构
[1] Univ Texas, Med Branch, Dept Internal Med, Div Gen Med, Galveston, TX 77555 USA
关键词
Jehovah's witnesses; bloodless medicine; erythropoietin; iron detran; factor VII; blood substitutes;
D O I
10.1016/j.amjmed.2006.04.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Jehovah's Witnesses are primarily known to physicians for their refusal of blood transfusions. Conflict arises at times with the medical staff concerning how best to manage their care. This article will begin with a brief description of the beliefs of Jehovah's Witnesses and will then recommend specific clinical strategies highlighting newer potential therapies according to the principles of bloodless medicine. The scenarios of bleeding and acute and chronic anemia will be discussed in detail for the care of these patients refusing red blood cell transfusions. An update in the use of blood substitutes will be mentioned as well as the surgical advances used today that can minimize blood loss for all patients. The experience of organ transplantation in Jehovah's Witnesses will be detailed. Further resources for physicians with questions in the care of these patients will be listed. Stressed throughout the article will be the need for a team approach and good communication between physicians to successfully care for their patients who are Jehovah's Witnesses. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1013 / 1018
页数:6
相关论文
共 52 条
[1]   Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness following chemotherapy for myeloid leukemia: a case report [J].
Agrawal, YP ;
Freedman, M ;
Szczepiorkowski, ZM .
TRANSFUSION, 2005, 45 (11) :1735-1738
[2]   Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: A multicenter, open-label, randomized trial [J].
Auerbach, M ;
Ballard, H ;
Trout, JR ;
McIlwain, M ;
Ackerman, A ;
Bahrain, H ;
Balan, S ;
Barker, L ;
Rana, J .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1301-1307
[3]   Meeting the clinical challenge of care for Jehovah's Witnesses [J].
Bodnaruk, ZM ;
Wong, CJ ;
Thomas, MJ .
TRANSFUSION MEDICINE REVIEWS, 2004, 18 (02) :105-116
[4]   Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials [J].
Boffard, KD ;
Riou, B ;
Warren, B ;
Choong, PIT ;
Rizoli, S ;
Rossaint, R ;
Axelsen, M ;
Kluger, Y .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01) :8-16
[5]   Kidney and pancreas transplants in Jehovah's witnesses: Ethical and practical implications [J].
Boggi, U ;
Vistoli, F ;
Del Chiaro, M ;
Croce, C ;
Signori, S ;
Marchetti, P ;
Del Prato, S ;
Rizzo, G ;
Mosca, F .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) :601-602
[6]   Evolving trends in the care of polytrauma patients [J].
Bose, D ;
Tejwani, NC .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2006, 37 (01) :20-28
[7]   Transfusion triggers:: A systematic review of the literature [J].
Carson, JL ;
Hill, S ;
Carless, P ;
Hébert, P ;
Henry, D .
TRANSFUSION MEDICINE REVIEWS, 2002, 16 (03) :187-199
[8]   Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion [J].
Carson, JL ;
Noveck, H ;
Berlin, JA ;
Gould, SA .
TRANSFUSION, 2002, 42 (07) :812-818
[9]  
CARSON JL, 2006, JAMA-J AM MED ASSOC, V288, P2884
[10]  
COLOMBO F, 2005, CHIR ITAL, V6, P695